127 related articles for article (PubMed ID: 34676796)
21. [The German registry of individuals with alpha-1-antitrypsin deficiency--a source for research on patient care].
Koczulla R; Bittkowski N; Andress J; Greulich T; Schroth S; Kotke V; Vogelmeier C; Bals R
Pneumologie; 2008 Nov; 62(11):655-8. PubMed ID: 18855308
[TBL] [Abstract][Full Text] [Related]
22. The impact of smoke exposure on the clinical phenotype of alpha-1 antitrypsin deficiency in Ireland: exploiting a national registry to understand a rare disease.
O'Brien ME; Pennycooke K; Carroll TP; Shum J; Fee LT; O'Connor C; Logan PM; Reeves EP; McElvaney NG
COPD; 2015 May; 12 Suppl 1():2-9. PubMed ID: 25938284
[TBL] [Abstract][Full Text] [Related]
23. Relationship of the 2011 Global Initiative for Chronic Obstructive Lung Disease strategy to clinically relevant outcomes in individuals with α1-antitrypsin deficiency.
Pillai AP; Turner AM; Stockley RA
Ann Am Thorac Soc; 2014 Jul; 11(6):859-64. PubMed ID: 24950156
[TBL] [Abstract][Full Text] [Related]
24. Lung function and CT lung densitometry in 37- to 39-year-old individuals with alpha-1-antitrypsin deficiency.
Mostafavi B; Diaz S; Piitulainen E; Stoel BC; Wollmer P; Tanash HA
Int J Chron Obstruct Pulmon Dis; 2018; 13():3689-3698. PubMed ID: 30510411
[TBL] [Abstract][Full Text] [Related]
25. The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency: results from the Austrian Alpha-1 Lung Registry.
Meischl T; Schmid-Scherzer K; Vafai-Tabrizi F; Wurzinger G; Traunmüller-Wurm E; Kutics K; Rauter M; Grabcanovic-Musija F; Müller S; Kaufmann N; Löffler-Ragg J; Valipour A; Funk GC
Respir Res; 2023 Jan; 24(1):34. PubMed ID: 36707810
[TBL] [Abstract][Full Text] [Related]
26. Differences in adjustment between individuals with alpha-1 antitrypsin deficiency (AATD)-associated COPD and non-AATD COPD.
Holm KE; Borson S; Sandhaus RA; Ford DW; Strange C; Bowler RP; Make BJ; Wamboldt FS
COPD; 2013 Apr; 10(2):226-34. PubMed ID: 23547634
[TBL] [Abstract][Full Text] [Related]
27. Is an integrative laboratory algorithm more effective in detecting alpha-1-antitrypsin deficiency in patients with premature chronic obstructive pulmonary disease than AAT concentration based screening approach?
Beletic A; Dudvarski-Ilic A; Milenkovic B; Nagorni-Obradovic L; Ljujic M; Djordjevic V; Mirkovic D; Radojkovic D; Majkic-Singh N
Biochem Med (Zagreb); 2014; 24(2):293-8. PubMed ID: 24969923
[TBL] [Abstract][Full Text] [Related]
28. The Swedish α1-Antitrypsin Screening Study: Health Status and Lung and Liver Function at Age 34.
Tanash HA; Nystedt-Düzakin M; Montero LC; Sveger T; Piitulainen E
Ann Am Thorac Soc; 2015 Jun; 12(6):807-12. PubMed ID: 25803183
[TBL] [Abstract][Full Text] [Related]
29. Liver function in alpha-1-antitrypsin deficient individuals at 37 to 40 years of age.
Mostafavi B; Diaz S; Tanash HA; Piitulainen E
Medicine (Baltimore); 2017 Mar; 96(12):e6180. PubMed ID: 28328804
[TBL] [Abstract][Full Text] [Related]
30. The United States Alpha-1 Foundation Research Registry: Genesis, Impact and Future.
Strange C; Monk R; Schwarz L; Walker D; Kumbhare S; Bieko T
COPD; 2015 May; 12 Suppl 1():42-5. PubMed ID: 25938291
[TBL] [Abstract][Full Text] [Related]
31. Severe alpha-1-antitrypsin deficiency increases the risk of venous thromboembolism.
Basil N; Ekström M; Piitulainen E; Lindberg A; Rönmark E; Jehpsson L; Tanash H
J Thromb Haemost; 2021 Jun; 19(6):1519-1525. PubMed ID: 33763945
[TBL] [Abstract][Full Text] [Related]
32. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
Rahaghi FF; Miravitlles M
Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
[TBL] [Abstract][Full Text] [Related]
33. The natural history of lung function after lung transplantation for α(1)-antitrypsin deficiency.
Banga A; Gildea T; Rajeswaran J; Rokadia H; Blackstone EH; Stoller JK
Am J Respir Crit Care Med; 2014 Aug; 190(3):274-81. PubMed ID: 25003824
[TBL] [Abstract][Full Text] [Related]
34. Decreased Risk of Ischemic Heart Disease in Individuals with Severe Alpha 1-Antitrypsin Deficiency (PiZZ) in Comparison with the General Population.
Tanash H; Ekström M; Basil N; Rönmark E; Lindberg A; Piitulainen E
Int J Chron Obstruct Pulmon Dis; 2020; 15():1245-1252. PubMed ID: 32606637
[TBL] [Abstract][Full Text] [Related]
35. [Detection of alpha-1 antitrypsin deficiency: A study on patients diagnosed with chronic obstructive pulmonary disease in primary health care].
García-Palenzuela R; Timiraos Carrasco R; Gómez-Besteiro MI; Lavia G; Lago Pose M; Lara B
Semergen; 2017; 43(4):289-294. PubMed ID: 27353138
[TBL] [Abstract][Full Text] [Related]
36. European screening for alpha
Greulich T; Averyanov A; Borsa L; Rozborilová E; Vaicius D; Major T; Chopyak V; Tudorache V; Konstantinova T; Camprubí S
Clin Respir J; 2017 Jan; 11(1):90-97. PubMed ID: 25919395
[TBL] [Abstract][Full Text] [Related]
37. Blood monocyte profiles in COPD patients with PiMM and PiZZ α1-antitrypsin.
Stolk J; Aggarwal N; Hochnadel I; Wrenger S; Martinez-Delgado B; Welte T; Yevsa T; Janciauskiene S
Respir Med; 2019 Mar; 148():60-62. PubMed ID: 30827477
[TBL] [Abstract][Full Text] [Related]
38. The prevalence of alpha-1 antitrypsin deficiency among patients found to have airflow obstruction.
Rahaghi FF; Sandhaus RA; Brantly ML; Rouhani F; Campos MA; Strange C; Hogarth DK; Eden E; Stocks JM; Krowka MJ; Stoller JK
COPD; 2012 Aug; 9(4):352-8. PubMed ID: 22506682
[TBL] [Abstract][Full Text] [Related]
39. Medical costs of Alpha-1 antitrypsin deficiency-associated COPD in the United States.
Sieluk J; Slejko JF; Silverman H; Perfetto E; Mullins CD
Orphanet J Rare Dis; 2020 Sep; 15(1):260. PubMed ID: 32967697
[TBL] [Abstract][Full Text] [Related]
40. Sex differences in alpha-1-antitrypsin deficiency lung disease-analysis from the German registry.
Fähndrich S; Herr C; Greulich T; Seibert M; Lepper PM; Bernhard N; Lützow C; Vogelmeier C; Bals R
COPD; 2015 May; 12 Suppl 1():58-62. PubMed ID: 25938294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
